Economy

Antares Pharma, Inc. (ATRS) Valuation According To Analysts

The stock is trading $3.05 its 50-day moving average by -0.02%. Note, this compares with a consensus analyst forecast of -0.03 in earnings per share for its next fiscal quarterly report. Beta, which measures a stock's price volatility relative to the market, provides the cleanest measure of systematic risk for a stock. On a monthly basis the stock is 0.31%.

What do the trading volumes reveal? It has outperformed by 129.11% the S&P500.

All these opinions have come together to present the composite price target for the stock. The business had revenue of $13.42 million during the quarter, compared to analyst estimates of $12.99 million. Broadfin Capital Llc who had been investing in Antares Pharma Inc for a number of months, seems to be less bullish one the $467.66M market cap company. The stock declined 2.05% or $0.55 reaching $26.25 on the news.

About 1.38M shares traded or 30.19% up from the average. Antares Pharma, Inc. has a 52-week low of 1.41 and a 52-week high of 3.37. It has outperformed by 190.44% the S&P500.

Antares Pharma, Inc. (ATRS)'s ROE is 0%, while industry's is 11.32%. They expect $-0.03 EPS, up 70.00% or $0.07 from last year's $-0.1 per share.

According to analysts Antares Pharma Cmn (NASDAQ:ATRS)'s minimum EPS for the current quarter is at $-0.04 and can go high up to $-0.02.

Since March 31, 2017, it had 1 insider buy, and 3 insider sales for $35,244 activity. During last 3 month period, 15.58% of total institutional ownership has changed in the company shares. On Friday, March 31 the insider GARRITY THOMAS J sold $87,276. It also increased its holding in Ignyta Inc (NASDAQ:RXDX) by 303,901 shares in the quarter, for a total of 2.94M shares, and has risen its stake in La Jolla Pharmaceutical Co (NASDAQ:LJPC).

Among 4 analysts covering Antares Pharma (NASDAQ:ATRS), 4 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Antares Pharma had 6 analyst reports since March 9, 2016 according to SRatingsIntel. Bank of America maintained it with "Underperform" rating and $17 target in Tuesday, July 25 report. H.C. Wainwright initiated Antares Pharma Inc (NASDAQ:ATRS) rating on Friday, June 23. The 100-day moving average verse price signal is Buy. Many keen investors will approach stock research from various angles. The company was initiated on Friday, September 8 by H.C. Wainwright. Antares Pharma now has a consensus rating of Buy and an average target price of $4.34. Piper Jaffray has "Buy" rating and $400 target. Its down 0.80, from 2.87 in 2017Q1. ATRS's SI was 6.05 million shares in September as released by FINRA. Voya Investment Mgmt Ltd Liability Corp has invested 0% in Antares Pharma Inc (NASDAQ:ATRS). Antares Pharma earned a media sentiment score of 0.21 on Accern's scale. Benjamin F Edwards And, Missouri-based fund reported 4,751 shares.

How Active Are Antares Pharma, Inc. Antares Pharma Inc (NASDAQ:ATRS) has risen 207.14% since September 25, 2016 and is uptrending. Sii Invs Wi owns 15,800 shares or 0% of their U.S. portfolio. Geode Cap Management Limited Liability owns 1.19 million shares.

Investors sentiment increased to 1.29 in 2017 Q2. Baystate Wealth Ltd owns 350 shares. Toronto Dominion Bancshares has 0% invested in Twitter Inc (NYSE:TWTR) for 7,592 shares. The stock's beta is 1.17 whilst the stock has an average true range (ATR) of 0.57. Miller Howard Invs Ny has 131,648 shares for 0.1% of their portfolio. Ohio-based Keybank Natl Association Oh has invested 0% in Twitter Inc (NYSE:TWTR). Barclays Public Limited Com accumulated 0% or 30,694 shares. Hightower Advisors Ltd Liability reported 12,600 shares stake. Usca Ria Lc stated it has 1.83% of its portfolio in Main Street Capital Corporation (NYSE:MAIN). Focused Wealth reported 0.25% stake. Blackrock holds 0% or 9.18 million shares. Its down 12.43% from 6.91M shares previously. Therefore 14% are positive. RBC Capital Markets maintained the shares of LOW in report on Wednesday, August 23 with "Buy" rating. The rating was maintained by Keefe Bruyette & Woods on Thursday, July 27 with "Hold". The rating was downgraded by SunTrust to "Neutral" on Friday, April 29. The firm has "Neutral" rating given on Monday, August 28 by Susquehanna. On Thursday, November 19 the stock rating was upgraded by Zelman to "Buy". The company saw 2.09 million shares trade hands over the course of the day. (NYSE:LOW) on Wednesday, August 23 with "Hold" rating.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.



Like this

Latest


29 September 2017
Starwood Property Trust, Inc. (STWD) Holdings Decreased by Veritable LP
Finally, ValuEngine lowered Starwood Property Trust from a "buy" rating to a "hold" rating in a report on Tuesday, September 12th. Livforsakringsbolaget Skandia Omsesidigt bought 3,900 shares as the company's stock declined 1.76% while stock markets rallied.

29 September 2017
DA studying Zuma implementing state capture recommendations judgment
The DA argued Zuma is compelled to implement the remedial action even though the court still has to consider Zuma's reservations. The Nkandla judgment past year held that the public protector's remedial action is binding unless set aside by the court.

29 September 2017
Thermo Fisher Scientific Inc. (TMO)
Barclays Public Ltd stated it has 0% of its portfolio in Codexis, Inc. 344 were reported by Howe Rusling Inc. (ARNC) to grow. Thermo Fisher Scientific (NYSE:TMO) last announced its quarterly earnings results on Tuesday, January 31st. (NASDAQ:AAPL).

29 September 2017
Governor grateful for help on pipeline costs
House Majority Leader Al Carlson, R-Fargo, said state leaders hope the federal government will pick up the remaining $18 million. This week, the state Emergency Commission and the Legislature's Budget Section voted to accept a $10 million grant from the U.S.

29 September 2017
The Travelers Companies, Inc. (NYSE:TRV) Shares Sold by Prudential Financial Inc
Ems Capital Lp who had been investing in Jd Com Inc for a number of months, seems to be bullish on the $57.48B market cap company. The Travelers Companies, Inc. has a beta of 0.41, offering the possibility of a higher rate of return, but also posing more risk.

29 September 2017
Golmaal Again song 'Maine Tujhko Dekha' released!
Golmaal Again is the fourth installment of the Golmaal film franchise and marks Devgn's tenth film collaboration with Shetty. Also starring Neil Nitin Mukesh, Johnny Lever, Mukesh Tiwari, and Sanjai Mishra, the film releases on October 20.

29 September 2017
Julia Louis-Dreyfus diagnosed with breast cancer
However, her publicist told the Associated Press that she "is incredibly grateful for the outpouring of support and well wishes". The Veep star uploaded a short but poignant message to her Twitter account after learning that she had breast cancer .

29 September 2017
DeVos awards IN $59M for charter school expansion
State schools Superintendent Jennifer McCormick says the $59 million will be spread out over five years. The money is meant to pay for students to attend charter schools and for planning and program design.

29 September 2017
Technical Spotlight: Tracking Shares of Invesco Municipal Trust (VKQ)
Shares of Invesco Municipal Income Opportunities Trust ( NYSE OIA ) traded down 0.13% during trading on Thursday, reaching $7.90. Invesco Van Kampen Trust For Investment Grade Municipals's Williams Percent Range or 14 day Williams %R now sits at -86.67.

29 September 2017
Negligence behind rabies deaths, say health experts
Initial symptoms include a fever with pain and unusual or unexplained tingling, pricking or burning sensation at the wound site. The research team concluded that the decrease in mortality couldn't be explained by a reduction in deaths due to rabies alone.



Recommended